Open Access<p>PD-L1 and miR-34a are Prognostic Factors for Primary Gastric Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP</p>
Author(s) -
Jinfeng Wang,
Song Shang,
Junjun Li,
Hongyu Deng,
Linda Ouyang,
Haiyang Xie,
Haizhen Zhu,
Yajun Li,
Chaohui Zuo
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s247874
Subject(s) - medicine , prednisone , vincristine , rituximab , gastroenterology , chop , stage (stratigraphy) , b symptoms , cyclophosphamide , lymphoma , immunohistochemistry , chemotherapy , biology , paleontology
Primary gastric diffuse large B-cell lymphoma (GDLBCL) is a heterogeneous disease in clinicopathological features and prognosis. Programmed death ligand-1 (PD-L1) and microRNA-34a (miR-34a) play crucial roles in GDLBCL progress. The purpose of this research is to explore the clinical significance of PD-L1 and miR-34a expression in GDLBCL.